Abacus Health Products, Inc. (ABAHF) is pleased to announce that it has acquired the principal assets of the companies owning the Harmony Hemp™ brand for an aggregate consideration of US$5.5 million, payable in cash and subordinate voting shares of Abacus over a 24 month period in accordance with the terms of the acquisition agreement entered into on February 10, 2020.
SpendEdge has been monitoring the global clinical research services market and the market is poised to experience spend growth of more than USD 14 billion between 2019-2024 at a CAGR of over 6% during the forecast period. This press release features multimedia.
Vizient, Inc. today praised the work of the House and Senate in approving year-end spending legislation that includes the Creating and Restoring Equal Access to Equivalent Samples Act. The CREATES Act prevents brand name drug manufacturers from using tactics that slow the development and entry of new, lower cost generic drugs into the marketplace, such as blocking access to samples.
PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Human Care Systems as one of the most innovative companies of 2019.
Science-focused product line is backed by global cannabis leader Panaxia Pharmaceutical Industries Ocean Grown Ventures, a science-focused cannabis company offering wellness solutions that meet pharmaceutical manufacturing standards, today announced the launch of Tikva, a full-spectrum hemp-derived CBD product line, designed to provide consumers consistent and high quality health and wellness...
SpendEdge, a global procurement market intelligence firm, has announced the release of its Global Drug Intermediates and APIs Market - Procurement Intelligence Report. This press release features multimedia. The drug intermediates and APIs market is set to witness a spend growth of more than USD 80 billion with the spend momentum accelerating at a CAGR of more than 6% through 2024.
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.
